{"id":"W2794420720","doi":"10.1016/j.ahj.2018.03.001","title":"An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial","year":2018,"lang":"en","type":"article","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta; St. Michael's Hospital; Canadian VIGOUR Centre","funders":"Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Apixaban; Acute coronary syndrome; Vitamin K antagonist; Percutaneous coronary intervention; Aspirin; Internal medicine; Atrial fibrillation; Myocardial infarction; Randomized controlled trial; Cardiology; Conventional PCI; Antithrombotic; Stroke (engine); Coronary artery disease; Warfarin; Rivaroxaban","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002430541,0.0002136702,0.001465573,0.0001409008,0.0002854729,0.0001081647,0.0001069866,0.00005258388,0.00006291932],"category_scores_gemma":[0.0005747286,0.0001098413,0.000110163,0.0002056161,0.0007312965,0.0002498759,0.0001334015,0.0001463221,4.020331e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005226818,"about_ca_system_score_gemma":0.0001766148,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008272413,"about_ca_topic_score_gemma":0.00002340897,"domain_scores_codex":[0.9965301,0.001544827,0.0009898304,0.0002602341,0.0004988398,0.0001762168],"domain_scores_gemma":[0.9974744,0.001420829,0.0005839949,0.0001842449,0.000200081,0.000136393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9404469,0.00004458911,0.05642129,0.00001171516,0.0005304014,0.000008765732,0.0003823041,0.00003110058,0.0001580002,0.00001572933,0.00006043939,0.00188875],"study_design_scores_gemma":[0.8259553,0.02524085,0.1463085,0.0001143099,0.0006978991,0.000416826,0.0001631901,0.0008220696,0.000007342022,0.00002849007,0.0001212815,0.0001239647],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9872707,0.00008269525,0.0002440447,0.001306289,0.0005098906,0.0105529,0.00001971883,0.000006627776,0.000007097761],"genre_scores_gemma":[0.9980192,0.0002119296,0.0009837555,0.0001119058,0.0005428945,0.00001063481,0.00001204812,0.000018779,0.00008881149],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1144916,"threshold_uncertainty_score":0.4479198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03782941610953171,"score_gpt":0.3404419259891938,"score_spread":0.3026125098796621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}